News Conference News VIVA 2024 Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK L.A. McKeown November 05, 2024
News Daily News Scientific Statement Reviews Current Antithrombotic Options in PAD L.A. McKeown August 26, 2024
News Conference News TCT 2023 LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI L.A. McKeown October 25, 2023
News Conference News ACC 2020 New Questions About Triple Therapy After PAD Revascularization: VOYAGER PAD Substudy L.A. McKeown April 02, 2020
News Daily News IN.PACT Admiral Data Show No Death Difference at 5 Years for Paclitaxel DCBs vs PTA in Femoropopliteal Disease L.A. McKeown January 25, 2019
News Conference News VIVA 2018 Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease L.A. McKeown November 15, 2018
News Conference News ACC 2018 COMPASS Approach Helps With Leg Complications in Patients With PAD Todd Neale March 12, 2018
News Daily News Extended DAPT May Benefit Patients With CAD and PAD, but With Caveats L.A. McKeown May 03, 2017
News Daily News Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond December 23, 2015
News Daily News Zilver PTX 2-Year Results Published: Superior Safety, Efficacy vs. Angioplasty Sustained April 12, 2013
News Daily News First DES for Above-the-Knee Vascular Disease on the Horizon L.A. McKeown October 18, 2011
News Conference News Paclitaxel-Eluting Balloon Shows Positive Results in Peripheral Disease Jason Kahn May 17, 2011